Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Sionneau

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|January 1, 2019
Laura Salabert, Baptiste Sionneau, Valérie Cochin, et al.
Clinical Genitourinary Cancer|May 22, 2019
Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the LiteratureManon de Vries-Brilland, Baptiste Sionneau, Caroline Dutriaux, et al.
Cancer Management and Research|October 16, 2020
Management of Immune Checkpoint Inhibitor ToxicitiesQuentin Durrechou, Charlotte Domblides, Baptiste Sionneau, et al.
Expert Opinion on Biological Therapy|April 5, 2020
Atezolizumab for the treatment of renal cell carcinomaMathilde Lafon, Charlotte Domblides, Amaury Daste, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A reviewMathieu Larroquette, Charlotte Domblides, Félix Lefort, et al.
Cancers|December 9, 2023
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical PracticeFélix Lefort, Yasmine Rhanine, Mathieu Larroquette, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Joint Bone Spine|October 24, 2024
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational studyAlexandra Ladouceur, Thomas Barnetche, Sorilla Prey, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2021
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse eventsMarie Kostine, Eleonora Mauric, Alice Tison, et al.
RMD Open|November 29, 2023
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational studyAlexandra Ladouceur, Thomas Barnetche, Gael Mouterde, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|January 1, 2019
Laura Salabert, Baptiste Sionneau, Valérie Cochin, et al.
Clinical Genitourinary Cancer|May 22, 2019
Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the LiteratureManon de Vries-Brilland, Baptiste Sionneau, Caroline Dutriaux, et al.
Cancer Management and Research|October 16, 2020
Management of Immune Checkpoint Inhibitor ToxicitiesQuentin Durrechou, Charlotte Domblides, Baptiste Sionneau, et al.
Expert Opinion on Biological Therapy|April 5, 2020
Atezolizumab for the treatment of renal cell carcinomaMathilde Lafon, Charlotte Domblides, Amaury Daste, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A reviewMathieu Larroquette, Charlotte Domblides, Félix Lefort, et al.
Cancers|December 9, 2023
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical PracticeFélix Lefort, Yasmine Rhanine, Mathieu Larroquette, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Joint Bone Spine|October 24, 2024
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational studyAlexandra Ladouceur, Thomas Barnetche, Sorilla Prey, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2021
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse eventsMarie Kostine, Eleonora Mauric, Alice Tison, et al.
RMD Open|November 29, 2023
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational studyAlexandra Ladouceur, Thomas Barnetche, Gael Mouterde, et al.
Pageof 1